Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Atorvastatin (10mg) + Fenofibrate (145mg) Tablet
Therapeutic Category
Cardiology, Cardiovascular
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
10*10
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Atorable F 145 Tablet containing Atorvastatin and Fenofibrate is used for the management of abnormal lipid levels and cardiovascular risk factors. It helps maintain healthy cholesterol and triglyceride levels and supports overall heart health.
Atorvastatin works by reducing the production of cholesterol in the liver, while Fenofibrate helps lower triglyceride levels and improve lipid metabolism. Together, they provide comprehensive lipid management support.
The tablet is widely prescribed in cardiac and general medicine practice for patients requiring combined cholesterol and triglyceride management, leading to consistent prescription demand.
With increasing awareness of cardiovascular wellness and lipid management, this product offers strong business potential for retailers and distributors. Its dual-action lipid-lowering approach, established therapeutic relevance, and steady market demand make it a reliable product for growth in the cardiac care segment.
Some patients may experience headache, nausea, abdominal discomfort, indigestion, muscle pain, weakness, or elevated liver enzymes. Rarely, severe muscle-related disorders, pancreatitis, liver dysfunction, or allergic reactions may occur and require immediate medical attention.
Atorable F 145 Tablet is indicated for mixed dyslipidemia, hypertriglyceridemia, elevated cholesterol levels, and lipid disorders that require combined cholesterol and triglyceride management. It helps improve lipid parameters and supports cardiovascular health when used alongside appropriate lifestyle modifications.
This medicine should be used strictly under the supervision of a qualified healthcare professional. Regular monitoring of lipid profile, liver function, and muscle-related symptoms may be required during treatment. Use cautiously in patients with liver disease, kidney impairment, gallbladder disease, or a history of muscle disorders.
Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.
Composition : Atorvastatin 10mg + Aspirin 75mg + Clopidogrel 75mg Capsule
Composition : Atorvastatin (10mg) + Aspirin (75mg) Capsule
Composition : Atorvastatin Calcium I.P. 20mg + Clopidogrel I.P. 75mg + Aspirin I.P. 75mg Capsules
Composition : Atorvastatin Calcium I.P. 10mg + Clopidogrel I.P. 75mg Tablets
Composition : Atorvastatin Calcium I.P. 10mg + Aspirin I.P. 75mg Capsules
Composition : Atorvastatin Calcium I.P. 80mg Tablets
Composition : Atorvastatin Calcium I.P. 40mg Tablets
Composition : Atorvastatin Calcium I.P. 10mg Tablets
Composition : Atorvastatin Calcium I.P. 20mg Tablets
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Atorvastatin 10mg + Fenofibrate 145mg Tablet has strong demand in the cardiology, lipid management, and chronic disease segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on cardiovascular and metabolic care portfolios.
Medical distributors and agencies can benefit from consistent demand for cholesterol and triglyceride management under medical supervision. Atorvastatin 10mg is a statin that helps lower LDL cholesterol and reduce cardiovascular risk Fenofibrate 145mg helps reduce triglycerides and improve lipid profile Commonly prescribed for dyslipidemia, mixed hyperlipidemia, and prevention of cardiovascular diseases such as heart attack and stroke Provides dual lipid control (cholesterol + triglycerides) in a single formulation Widely used by cardiologists, diabetologists, and general physicians This strengthens a comprehensive cardiology and metabolic disorder portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Atorvastatin + Fenofibrate Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from high chronic prescription demand, long-term usage, repeat monthly sales, and strong cardiology market presence, along with reliable supply chain support and attractive margins in the lipid management segment.
Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to explore PCD pharma franchise opportunities, discuss pricing and business terms, obtain monopoly territory rights, and benefit from professional pharmaceutical support and a dependable supply chain for long-term business growth.